Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by Stocktreeon Oct 03, 2016 2:52pm
206 Views
Post# 25303382

Numbers impossible, anomaly/cheat... correct me maybe

Numbers impossible, anomaly/cheat... correct me maybeMortality of patients non-randomized because no consent form signed (surrogate group that would likely be similar to placebo group) = 62% (should be close to placebo)
Composite mortality = 45%
Absolute benefit compared to placebo group = 5% (much lower than expected)
 
Placebo (SOC) group = 47.5% mortality?
Treated group = 42.5% mortality?
 
Is the 176 patient group representative of a normal MODS 9+, elevated endotoxin level group?
 
Were other factors really badly affecting our hand?
 
Has the SOC treatment of really sick septic shock patients suddenly improved?
 
Why is the SOC+randomized group so different than the non-consent group (47.5? vs 62%)?
 
There is either a statistical anomaly going on, or we have been/are being cheated!

Bullboard Posts